TEOA Inhibits Proliferation and Induces DNA Damage of Diffuse Large B-Cell Lymphoma Cells Through Activation of the ROS-Dependent p38 MAPK Signaling Pathway

• Main Authors: Xingxing Yu (Author), Xin Wang (Author), Xu Wang (Author), Yi Zhou (Author), Yanchun Li (Author), Aiwei Wang (Author), Tongtong Wang (Author), Yihan An (Author), Weidong Sun (Author), Jing Du (Author), Xiangmin Tong (Author), Ying Wang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of lymphoma, accounting for approximately 30% to 40% of non-Hodgkin's lymphomas (NHL). The administration of rituximab significantly improved the outcomes of DLBCL; however, the unavoidable development of resistance limits the lon...